Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fusion Proteins: Aflibercept (VEGF Trap-Eye).
Sarwar S, Bakbak B, Sadiq MA, Sepah YJ, Shah SM, Ibrahim M, Do DV, Nguyen QD. Sarwar S, et al. Among authors: sadiq ma. Dev Ophthalmol. 2016;55:282-94. doi: 10.1159/000439008. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501481 Review.
Future Perspectives: Agents on the Horizon.
Maya JR, Sadiq MA, Agarwal A, Kaiser PK, Stoller GL, Sepah YJ, Nguyen QD. Maya JR, et al. Among authors: sadiq ma. Dev Ophthalmol. 2016;55:391-8. doi: 10.1159/000439037. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501694 Review.
Sirolimus for Retinal and Uveitic Diseases.
Agarwal A, Rajagopalan N, Hassan M, Sadiq MA, Soliman MK, Afridi R, Sepah YJ, Nguyen QD. Agarwal A, et al. Among authors: sadiq ma. Dev Ophthalmol. 2016;55:276-81. doi: 10.1159/000438951. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26501229 Review.
Aflibercept for neovascular age-related macular degeneration.
Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD. Sarwar S, et al. Among authors: sadiq ma. Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2. Cochrane Database Syst Rev. 2016. PMID: 26857947 Free PMC article. Review.
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study.
Sepah YJ, Sadiq MA, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus D, Halperin L, Hassan M, Campochiaro PA, Nguyen QD, Do DV; READ-3 Study Group. Sepah YJ, et al. Among authors: sadiq ma. Ophthalmology. 2016 Dec;123(12):2581-2587. doi: 10.1016/j.ophtha.2016.08.040. Epub 2016 Oct 1. Ophthalmology. 2016. PMID: 27707550 Clinical Trial.
114 results